Maynard Um
-
-
-
-
-
-
-
Callan JMB to oversee Attune Biotech's Long COVID drug manufacturing
-
-
-
-
-
-
-
Callan JMB Inc. (NASDAQ:CJMB) Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility
-
-
-
-
-
-
-
Callan JMB (CJMB) Opens At $4, IPO Priced At $4
433,990 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

